Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis

Virgili, Gianni; Curran, Katie; Lucenteforte, Ersilia; Parravano, Mariacristina

doi:10.1002/14651858.cd007419.pub7

Cited by 6 publications

(1 citation statement)

References 127 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this work, we present a non‐conventional meta‐analysis that consist in indirect comparisons, for this reason in this work we made different separations by subgroups since according to the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy we can do that through perform subgroup analyses, the different subgroups being defined by the different comparisons being made 36,37 . This method is common in a multiple‐treatments meta‐analysis (MTM) usually called network meta‐analysis 38,39 …”

Section: Discussionmentioning

confidence: 99%

Participation of lncRNAs in the development of diabetic complications: Systematic review and meta‐analysis. I. Rat

Cabrera‐Najera,

Chirino‐Galindo,

Palomar‐Morales

2023

Diabet Med

View full text Add to dashboard Cite

AimsWe evaluated the involvement of lncRNAs in the development of pathologies associated with chronic hyperglycemia in rat models in in a model of type 1, type 2 and gestational diabetes.MethodsReports were searched in Dialnet, Scielo, HINARI, Springer, ClinicalKey, OTseeker, PubMed and different grey literature databases with any restrictions. Bibliography databases will be searched from their inception to December 2022.ResultsThirty‐eight studies met our criteria, and they had the following characteristics: original experimental studies on diabetes, the lncRNAs were extracted or measured from tissues of specific areas, and the results were expressed in terms of standard measures by RT‐PCR. In most studies both primary and secondary outcomes were mentioned. On the other hand, we found a total of nine diabetic complications, being retinopathy, nephropathy, neuropathy, and liver damage the most representatives. Additionally, it was found that MALAT1, H19, NEAT1, and TUG1 are the most studied lncRNAs about these complications in rats. On the other hand, the lncRNAs with the highest rate of change were MSTRG.1662 (17.85; 13.78, 21.93), ENSRNOT00000093120_Aox3 (7.13; 5.95, 8.31) and NONRATG013497.2 (‐5.55; ‐7.18, ‐3.93).ConclusionsThis review found a significant involvement of lncRNAs in the progression of pathologies associated with chronic hyperglycemia in rat models, and further studies are needed to establish their potential as biomarkers and therapeutic targets for diabetes.

show abstract

Section: Discussionmentioning

confidence: 99%

Participation of lncRNAs in the development of diabetic complications: Systematic review and meta‐analysis. I. Rat

Cabrera‐Najera,

Chirino‐Galindo,

Palomar‐Morales

2023

Diabet Med

View full text Add to dashboard Cite

show abstract

How do anti-vascular endothelial growth factors compare with one another for people with diabetic macular edema?

Burch¹

2017

Cochrane Clinical Answers

View full text Add to dashboard Cite

How do anti-vascular endothelial growth factors (anti-VEGFs) compare with one another for people with diabetic macular edema?

Tort,

Anderson

2023

Cochrane Clinical Answers

View full text Add to dashboard Cite

Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis

Abstract: Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis (Review)

Cited by 6 publications

References 127 publications

Participation of lncRNAs in the development of diabetic complications: Systematic review and meta‐analysis. I. Rat

Participation of lncRNAs in the development of diabetic complications: Systematic review and meta‐analysis. I. Rat

How do anti-vascular endothelial growth factors compare with one another for people with diabetic macular edema?

How do anti-vascular endothelial growth factors (anti-VEGFs) compare with one another for people with diabetic macular edema?

Contact Info

Product

Resources

About